Short pages

Jump to navigation Jump to search

Showing below up to 50 results in range #11,671 to #11,720.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. (hist) Dyspnea case study one [297 bytes]
  2. (hist) Yaws other imaging findings [297 bytes]
  3. (hist) Relapsing fever screening [297 bytes]
  4. (hist) Relapsing fever natural history [297 bytes]
  5. (hist) Relapsing fever secondary prevention [297 bytes]
  6. (hist) Southern tick-associated rash illness historical perspective [297 bytes]
  7. (hist) Southern tick-associated rash illness risk factors [297 bytes]
  8. (hist) Southern tick-associated rash illness natural history, complications and prognosis [297 bytes]
  9. (hist) Southern tick-associated rash illness physical examination [297 bytes]
  10. (hist) Southern tick-associated rash illness cost-effectiveness of therapy [297 bytes]
  11. (hist) Southern tick-associated rash illness future or investigational therapies [297 bytes]
  12. (hist) Southern tick-associated rash illness case study one [297 bytes]
  13. (hist) Southern tick-associated rash illness other diagnostic studies [297 bytes]
  14. (hist) Japanese encephalitis cost-effectiveness of therapy [297 bytes]
  15. (hist) Tonsilitis historical perspective [297 bytes]
  16. (hist) Tonsilitis differential diagnosis [297 bytes]
  17. (hist) Tonsilitis epidemiology and demographics [297 bytes]
  18. (hist) Coronavirus other imaging findings [297 bytes]
  19. (hist) Tricyclic antidepressant overdose case study one [297 bytes]
  20. (hist) Tricyclic antidepressant overdose future or investigational therapies [297 bytes]
  21. (hist) Tricyclic antidepressant overdose cost-effectiveness of therapy [297 bytes]
  22. (hist) Tricyclic antidepressant overdose secondary prevention [297 bytes]
  23. (hist) Tricyclic antidepressant overdose primary prevention [297 bytes]
  24. (hist) Tricyclic antidepressant overdose other diagnostic studies [297 bytes]
  25. (hist) Tricyclic antidepressant overdose laboratory findings [297 bytes]
  26. (hist) Tricyclic antidepressant overdose physical examination [297 bytes]
  27. (hist) Tricyclic antidepressant overdose risk factors [297 bytes]
  28. (hist) Tricyclic antidepressant overdose differential diagnosis [297 bytes]
  29. (hist) Tricyclic antidepressant overdose causes [297 bytes]
  30. (hist) Tricyclic antidepressant overdose historical perspective [297 bytes]
  31. (hist) Tricyclic antidepressant overdose CT [297 bytes]
  32. (hist) Tricyclic antidepressant overdose MRI [297 bytes]
  33. (hist) Tricyclic antidepressant overdose other imaging findings [297 bytes]
  34. (hist) Dizziness other imaging findings [297 bytes]
  35. (hist) Hepatolithiasis case study one [297 bytes]
  36. (hist) Varicose veins echocardiography or ultrasound [297 bytes]
  37. (hist) Pityriasis rosea historical perspective [297 bytes]
  38. (hist) Pityriasis rosea classification [297 bytes]
  39. (hist) Pityriasis rosea epidemiology and demographics [297 bytes]
  40. (hist) Pityriasis rosea laboratory findings [297 bytes]
  41. (hist) Pityriasis rosea other imaging findings [297 bytes]
  42. (hist) Pityriasis rosea primary prevention [297 bytes]
  43. (hist) Pityriasis rosea pathophysiology [297 bytes]
  44. (hist) Pityriasis rosea secondary prevention [297 bytes]
  45. (hist) Pityriasis rosea cost-effectiveness of therapy [297 bytes]
  46. (hist) Pityriasis rosea future or investigational therapies [297 bytes]
  47. (hist) Pityriasis rosea case study one [297 bytes]
  48. (hist) Azithromycin labels and packages [297 bytes]
  49. (hist) Cystic nephroma risk factors [297 bytes]
  50. (hist) Disseminated intravascular coagulation other imaging findings [297 bytes]

View ( | ) (20 | 50 | 100 | 250 | 500)